SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0000945234-06-000274
Filing Date
2006-04-03
Accepted
2006-03-31 21:27:25
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2005 o30811e40vf.htm 40-F 41992
2 ANNUAL INFORMATION FORM OF THE REGISTRANT o30811exv99w1.htm EX-99.1 276965
3 CODE OF ETHICS o30811exv99w4.htm EX-99.4 4728
4 CONSENT OF ERNST & YOUNG LLP. o30811exv99w5.htm EX-99.5 2037
5 C.E.O. CERTIFICATION - RULE 13A-14(A) o30811exv99w6.htm EX-99.6 6535
6 C.F.O. CERTIFICATION - RULE 13A-14(A) o30811exv99w7.htm EX-99.7 7015
7 SECTION 906 C.E.O. CERTIFICATION o30811exv99w8.htm EX-99.8 2922
8 SECTION 906 C.F.O. CERTIFICATION o30811exv99w9.htm EX-99.9 3259
9 GRAPHIC o30811o3081100.gif GRAPHIC 3275
  Complete submission text file 0000945234-06-000274.txt   351618
Mailing Address 6190 AGRONOMY RD. 6TH FLOOR VANCOUVER A1 V6T 1Z3
Business Address 6190 AGRONOMY RD. 6TH FLOOR VANCOUVER A1 V6T 1Z3 1-604-677-6905
Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1130
Type: 40-F | Act: 34 | File No.: 000-29338 | Film No.: 06731105
SIC: 2834 Pharmaceutical Preparations